KCM
BMEZ icon

Kathmere Capital Management’s BlackRock Health Sciences Trust II BMEZ Stock Holding History

Kathmere Capital Management’s Portfolio BMEZ Stock Details BMEZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$211K Buy
13,723
+1,023
+8% +$14.7K 0.01% 620
2026
Q1 		$182K Buy
+12,700
New +$189K 0.01% 588

Other funds holding BMEZ

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
SCM
Saba Capital Management New York $3.9B AUM 12.9% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2.1B AUM 2.15% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $13B AUM 71.84% 1-Year Est. Return

Kathmere Capital Management's BMEZ Position: Q2 2026 in Review

Kathmere Capital Management increased its BlackRock Health Sciences Trust II (BMEZ) stake by 8.1% in Q2 2026, buying an estimated $14.7K and bringing the position to 13,723 shares worth $211K. The position accounts for 0.01% of the portfolio, ranked #620.

Kathmere Capital Management first reported a position in BMEZ in Q1 2026 and has held it in 2 quarters since. 88 funds tracked by Wall St. Rank hold BMEZ as of Q2 2026.

  • Kathmere Capital Management held 13,723 shares of BlackRock Health Sciences Trust II worth $211K as of Q2 2026.
  • Kathmere Capital Management bought 1,023 BlackRock Health Sciences Trust II shares in Q2 2026, an estimated $14.7K.
  • BlackRock Health Sciences Trust II made up 0.01% of Kathmere Capital Management's portfolio in Q2 2026, its #620 holding.
  • Kathmere Capital Management first reported a position in BlackRock Health Sciences Trust II in Q1 2026 and has held it in 2 quarters since.
  • 88 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust II as of Q2 2026.

Based on Kathmere Capital Management's 13F filing for Q2 2026, filed 29 Jul 2026.